Status:
RECRUITING
Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Coronary Angiography
Percutaneous Coronary Intervention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
While the reduced hemorrhagic risk of radial access for percutaneous coronary intervention compared to femoral access is well-established, its main complication remains radial artery occlusion, which ...
Detailed Description
Prevention of radial occlusion relies on optimal hemostasis and anticoagulation. Previous studies have demonstrated a decrease incidence of radial artery occlusion through hemostasis at the puncture s...
Eligibility Criteria
Inclusion
- Patients having 18 years old or older, regardless of gender, undergoing percutaneous radial coronary intervention
- Subject affiliated to a social protection health insurance
- Subject able to understand the objectives and risks of the research and to provide dated and signed consent
- Subject who has been informed of the results of the preliminary medical examination
Exclusion
- Contraindication to the use of heparin (history of heparin-induced thrombocytopenia)
- Very high bleeding risk defined by recent bleeding (\<6 months) of type 3 of the BARC classification
- Subject in an exclusion period (determined by a previous or ongoing study)
- Inability to give the subject enlightened information (subject in an emergency situation, difficulties in understanding the subject, etc.)
- Subject under safeguard of justice
- Subject under guardianship or curatorship
- Pregnancy
- Breastfeeding
- Patient on anticoagulant treatment: anti-vitamin K, direct oral anticoagulants (DOACs).
Key Trial Info
Start Date :
June 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT06890312
Start Date
June 5 2025
End Date
January 1 2026
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, Bas-Rhin, France, 67091